Recall events
/
Event 89995
Event summary
Timeline bucket April 09, 2022
Product types Device
Classifications Class I
Statuses Ongoing
Recalling firm wording Woodside Acquisitions Inc.
Dossier provenance
Source snapshots represented here
openFDA Device Enforcement
Report-date coverage
June 20, 2012–July 08, 2026
Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.
openFDA Device Recall
event_date_initiated coverage
June 01, 1997–June 30, 2026
Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.
How coverage and grouping work
Complete imported group
Every recalled product in this event
2 official enforcement rows
Product dates, classifications, firms, and source wording remain attached to their individual rows.
Opening this dossier never hides products that did not match a prior timeline filter.
device · product 1 of 2
Oral Rapid SARS-CoV-2 Antigen Rapid Test Kit; COVID 19 Test
Z-1044-2022
Recall number Z-1044-2022
Initiated April 09, 2022
Classification Class I
Status Ongoing
Quantity 34,240 units
App-derived interpretation
Unknown
reason.no_named_rule · v1.0.0
Firm distributed tests which have not been cleared or authorized for marketing or distribution in the United States.
These labels are deterministic app interpretations, not FDA categories.
Official device-enrichment evidence · Sourced
No Marketing Application
Enrichment source openFDA Device Recall
Exact join Official recall number Z-1044-2022
Source locator 0001-device-recall-0001-of-0001.json.zip#results[22310]
Snapshot SHA-256 77e96a0ce750de9fa4bb4737d40b653784372b5abe88b9de499ad51edd808a4b
Open official device record
Compare all device evidence states
Inspect official wording and provenance
Reason for recall Firm distributed tests which have not been cleared or authorized for marketing or distribution in the United States.
Distribution pattern US distributions to states of: AL and GA.
Official fact provenance
Dataset openFDA Device Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 1c273507f2e0fc8c5b330c3716a1392933bd90a42a460afcb7368f298d5cbd3a
Raw source locator 0001-device-enforcement-0001-of-0001.json.zip#results[35734]
FDA event record
· Exact recall-number query on openFDA
device · product 2 of 2
Joysbio SARS-CoV-2 Antigen Rapid Test Kit (Colloidal Gold); COVID 19 Test
Z-1045-2022
Recall number Z-1045-2022
Initiated April 09, 2022
Classification Class I
Status Ongoing
Quantity 17,000 units
App-derived interpretation
Unknown
reason.no_named_rule · v1.0.0
Firm distributed tests which have not been cleared or authorized for marketing or distribution in the United States.
These labels are deterministic app interpretations, not FDA categories.
Official device-enrichment evidence · Sourced
No Marketing Application
Enrichment source openFDA Device Recall
Exact join Official recall number Z-1045-2022
Source locator 0001-device-recall-0001-of-0001.json.zip#results[26861]
Snapshot SHA-256 77e96a0ce750de9fa4bb4737d40b653784372b5abe88b9de499ad51edd808a4b
Open official device record
Compare all device evidence states
Inspect official wording and provenance
Reason for recall Firm distributed tests which have not been cleared or authorized for marketing or distribution in the United States.
Distribution pattern US distributions to states of: AL and GA.
Official fact provenance
Dataset openFDA Device Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 1c273507f2e0fc8c5b330c3716a1392933bd90a42a460afcb7368f298d5cbd3a
Raw source locator 0001-device-enforcement-0001-of-0001.json.zip#results[32596]
FDA event record
· Exact recall-number query on openFDA
